GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹31 Cr | ₹46 Cr | ₹61 Cr | ₹47 Cr | ₹12 Cr |
What is the latest Net Current Assets ratio of GUJARAT THEMIS BIOSYN ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹31 Cr |
Mar2023 | ₹46 Cr |
Mar2022 | ₹61 Cr |
Mar2021 | ₹47 Cr |
Mar2020 | ₹12 Cr |
How is Net Current Assets of GUJARAT THEMIS BIOSYN Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹31 Cr | -32.40 | |
Mar2023 | ₹46 Cr | -24.14 | |
Mar2022 | ₹61 Cr | 28.91 | |
Mar2021 | ₹47 Cr | 302.70 | |
Mar2020 | ₹12 Cr | - |
Compare Net Current Assets of peers of GUJARAT THEMIS BIOSYN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUJARAT THEMIS BIOSYN | ₹3,552.9 Cr | -0.6% | 9% | 156.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,808.6 Cr | 0.6% | -5.3% | 51% | Stock Analytics |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUJARAT THEMIS BIOSYN | -0.6% |
9% |
156.8% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses